Point72 Asset Management
CNST

Point72 Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Point72 Asset Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-114,932
Closed -$2.69M – 1261
2021
Q1 		$2.69M Sell
114,932
-84,733
-42% -$2.57M 0.01% 685
2020
Q4 		$5.75M Sell
199,665
-870,329
-81% -$21.9M 0.03% 557
2020
Q3 		$21.7M Buy
1,069,994
+383,274
+56% +$9.36M 0.11% 257
2020
Q2 		$20.6M Sell
686,720
-840,255
-55% -$30.3M 0.13% 212
2020
Q1 		$48M Buy
1,526,975
+1,026,158
+205% +$35.7M 0.39% 60
2019
Q4 		$23.6M Buy
+500,817
New +$14.5M 0.12% 236

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management's CNST Position: Q2 2021 in Review

Point72 Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 114,932 shares — an estimated $2.69M sold.

Point72 Asset Management first reported a position in CNST in Q4 2019 and held it in 6 quarters. The position peaked at $48M in Q1 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Point72 Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Point72 Asset Management sold 114,932 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $2.69M.
  • Point72 Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
  • Point72 Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $48M in Q1 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.